Normal human pregnancy is considered a state of enhanced oxidative stress. In pregnancy, it plays important roles in embryo development, implantation, placental development and function, fetal development, and labor. However, pathologic pregnancies, including gestational diabetes mellitus (GDM), are associated with a heightened level of oxidative stress, owing to both overproduction of free radicals and/or a defect in the antioxidant defenses. This has important implications on the mother, placental function, and fetal well-being. Animal models of diabetes have confirmed the important role of oxidative stress in the etiology of congenital malformations; the relative immaturity of the antioxidant system facilitates the exposure of embryos and fetuses to the damaging effects of oxidative stress. Of note, there are only a few clinical studies evaluating the potential beneficial effects of antioxidants in GDM. Thus, whether or not increased antioxidant intake can reduce the complications of GDM in both mother and fetus needs to be explored. This review provides an overview and updated data on our current understanding of the complications associated with oxidative changes in GDM. Antioxid. Redox Signal. 15, 3061–3100.
Afkhami-ArdekaniM, RashidiM. Iron status in women with and without gestational diabetes mellitus. J Diabetes Complications, 23:194–198. 2009.
2.
AgarwalA, GuptaS, SharmaRK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol, 3:28. 2005.
3.
AguirreV, UchidaT, YenushL, DavisR, WhiteMF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)J Biol Chem, 275:9047–9054. 2000.
Al GhafliMH, PadmanabhanR, KatayaHH, BergB. Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses. Mol Cell Biochem, 261:123–135. 2004.
6.
AllenVM, ArmsonBA, WilsonRD, BlightC, GagnonA, JohnsonJA, LangloisS, SummersA, WyattP, FarineD, CraneJ, DelisleMF, Keenan-LindsayL, MorinV, SchneiderCE, Van AerdeJ. Society of Obstetricians Gynecologists of Canada. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can, 29:927–944. 2007.
7.
AnastasiouE, LekakisJP, AlevizakiM, PapamichaelCM, MegasJ, SouvatzoglouA, StamatelopoulosSF. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care, 21:2111–2115. 1998.
8.
ArtsIC, HollmanPC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr, 81:317S–325S. 2005.
9.
AugustinR. The protein family of glucose transport facilitators: it's not only about glucose after all. IUBMB Life, 62:315–333. 2010.
10.
AvignonA, SultanA. PKC-B inhibition: a new therapeutic approach for diabetic complications?Diabetes Metab, 32:205–213. 2006.
11.
BabawaleMO, LovatS, MayhewTM, LammimanMJ, JamesDK, LeachL. Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. Diabetologia, 43:1185–1196. 2000.
12.
BanCR, TwiggSM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manage, 4:575–596. 2008.
13.
BarbourLA, McCurdyCE, HernandezTL, KirwanJP, CatalanoPM, FriedmanJE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care, 30,Suppl 2:S112–S119. 2007.
14.
BarterPJ, RyeKA. High density lipoproteins and coronary heart disease. Atherosclerosis, 121:1–12. 1996.
15.
BastaG, LazzeriniG, MassaroM, SimonciniT, TanganelliP, FuC, KislingerT, SternDM, SchmidtAM, De CaterinaR. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation, 105:816–822. 2002.
16.
BastaG, SchmidtAM, De CaterinaR. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res, 63:582–592. 2004.
BasuroyS, BhattacharyaS, LefflerCW, ParfenovaH. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol, 296:C422–C432. 2009.
19.
BellamyL, CasasJP, HingoraniAD, WilliamsD. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet, 373:1773–1779. 2009.
20.
BiriA, OnanA, DevrimE, BabacanF, KavutcuM, DurakI. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta, 27:327–332. 2006.
21.
BitsanisD, GhebremeskelK, MoodleyT, CrawfordMA, DjahanbakhchO. Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids, 41:341–346. 2006.
22.
BlochW, FleischmannBK, LorkeDE, AndressenC, HopsB, HeschelerJ, AddicksK. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res, 43:675–684. 1999.
BoS, MenatoG, VilloisP, GambinoR, CassaderM, CotrinoI, Cavallo-PerinP. Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol, 201:158.e1–6. 2009.
25.
BogdanC. Nitric oxide and the immune response. Nat Immunol, 2:907–916. 2001.
26.
BohlenderJM, FrankeS, SteinG, WolfG. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol, 289:F645–F659. 2005.
27.
BoisvertMR, KoskiKG, SkinnerCD. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal Chem, 82:1133–1137. 2010.
28.
Borrego-DiazE, RosalesJC, ProverbioT, Teppa-GarranA, AndaluzR, AbadC, MarinR, ProverbioF. Effect of placental hypoxia on the plasma membrane Ca-ATPase (PMCA) activity and the level of lipid peroxidation of syncytiotrophoblast and red blood cell ghosts. Placenta, 29:44–50. 2008.
29.
BorrielloA, CucciollaV, Della RagioneF, GallettiP. Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis, 20:618–625. 2010.
30.
BoucheC, SerdyS, KahnCR, GoldfineAB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev, 25:807–830. 2004.
31.
BrownleeM. Biochemistry and molecular cell biology of diabetic complications. Nature, 414:813–820. 2001.
32.
BuchananTA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab, 86:989–993. 2001.
BuchananTA, XiangAH, PetersRK, KjosSL, BerkowitzK, MarroquinA, GoicoJ, OchoaC, AzenSP. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes, 49:782–788. 2000.
35.
BuhimschiIA, ZhaoG, PettkerCM, BahtiyarMO, MagloireLK, ThungS, FairchildT, BuhimschiCS. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol, 196:181.e1–13. 2007.
36.
BurnsJ, YokotaT, AshiharaH, LeanME, CrozierA. Plant foods and herbal sources of resveratrol. J Agric Food Chem, 50:3337–3340. 2002.
37.
ButteNF, HsuHW, ThotathucheryM, WongWW, KhouryJ, ReedsP. Protein metabolism in insulin-treated gestational diabetes. Diabetes Care, 22:806–811. 1999.
38.
CamuzcuogluH, ToyH, CakirH, CelikH, ErelO. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus. J Womens Health, 18:1435–1439. 2009.
39.
CaniPD. Gut microbiota and pregnancy, a matter of inner life. Br J Nutr, 101:1579–1580. 2009.
40.
CapobiancoE, JawerbaumA, RomaniniMC, WhiteV, PustovrhC, HigaR, MartinezN, MugnainiMT, SonezC, GonzalezE. 15-Deoxy-Delta(12,14)-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism. Reprod Fertil Dev, 17:423–433. 2005.
41.
CarewTE. Role of biologically modified low-density lipoprotein in atherosclerosis. Am J Cardiol, 64:18G–22G. 1989.
42.
CarrDB, UtzschneiderKM, HullRL, TongJ, WallaceTM, KodamaK, ShoferJB, HeckbertSR, BoykoEJ, FujimotoWY, KahnSE. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care, 29:2078–2083. 2006.
43.
CasanelloP, EscuderoC, SobreviaL. Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr Vasc Pharmacol, 5:69–84. 2007.
44.
CasanuevaE, ViteriFE. Iron and oxidative stress in pregnancy. J Nutr, 133:1700S–1708S. 2003.
45.
CatalanoPM, DragoNM, AminiSB. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. Am J Obstet Gynecol, 172:1464–1470. 1995.
46.
CatalanoPM, FarrellK, ThomasA, Huston-PresleyL, MencinP, de MouzonSH, AminiSB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr, 90:1303–1313. 2009.
47.
CatalanoPM, NizielskiSE, ShaoJ, PrestonL, QiaoL, FriedmanJE. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab, 282:E522–E533. 2002.
48.
CatalanoPM, TyzbirED, WolfeRR, RomanNM, AminiSB, SimsEA. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol, 167:913–919. 1992.
49.
CaugheyAB, ChengYW, StotlandNE, WashingtonAE, EscobarGJ. Maternal and paternal race/ethnicity are both associated with gestational diabetes. Am J Obstet Gynecol, 202:616.e1–5. 2010.
50.
Cavanal MdeF, GomesGN, FortiAL, RochaSO, Franco MdoC, FortesZB, GilFZ. The influence of L-arginine on blood pressure, vascular nitric oxide and renal morphometry in the offspring from diabetic mothers. Pediatr Res, 62:145–150. 2007.
51.
CederbergJ, BasuS, ErikssonUJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia, 44:766–774. 2001.
52.
CederbergJ, ErikssonUJ. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis. Birth Defects Res A Clin Mol Teratol, 73:498–505. 2005.
53.
CederbergJ, GalliJ, LuthmanH, ErikssonUJ. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes, 49:101–107. 2000.
54.
ChangTI, HoralM, JainSK, WangF, PatelR, LoekenMR. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia, 46:538–545. 2003.
55.
ChappellJH.Jr., WangXD, LoekenMR. Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis, 14:1472–1483. 2009.
56.
ChaudhariL, TandonOP, VaneyN, AgarwalN. Lipid peroxidation and antioxidant enzymes in gestational diabetics. Indian J Physiol Pharmacol, 47:441–446. 2003.
57.
ChekirC, NakatsukaM, NoguchiS, KonishiH, KamadaY, SasakiA, HaoL, HiramatsuY. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta, 27:225–233. 2006.
58.
ChuSY, CallaghanWM, KimSY, SchmidCH, LauJ, EnglandLJ, DietzPM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care, 30:2070–2076. 2007.
59.
Cindrova-DaviesT, Spasic-BoskovicO, JauniauxE, Charnock-JonesDS, BurtonGJ. Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol, 170:1511–1520. 2007.
60.
Cindrova-DaviesT, YungHW, JohnsJ, Spasic-BoskovicO, KorolchukS, JauniauxE, BurtonGJ, Charnock-JonesDS. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol, 171:1168–1179. 2007.
61.
ClossEI, BashaFZ, HabermeierA, ForstermannU. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide, 1:65–73. 1997.
62.
ColomiereM, PermezelM, LappasM. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J Mol Endocrinol, 44:213–223. 2010.
63.
ColomiereM, PermezelM, RileyC, DesoyeG, LappasM. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol, 160:567–578. 2009.
64.
This reference has been deleted.
65.
ConradKP, VernierKA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol, 257:R847–R853. 1989.
66.
CookeCLM, BrockelsbyJC, BakerPN, DavidgeST. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy, 22:173–184. 2003.
CoughlanMT, OlivaK, GeorgiouHM, PermezelJM, RiceGE. Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med, 18:921–927. 2001.
CoughlanMT, VervaartPP, PermezelM, GeorgiouHM, RiceGE. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta, 25:78–84. 2004.
72.
CoustanDR, LoweLP, MetzgerBE. The hyperglycemia and adverse pregnancy outcome (HAPO) study: can we use the results as a basis for change?J Matern Fetal Neonatal Med, 23:204–209. 2010.
73.
CuiXL, BrockmanD, CamposB, MyattL. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta, 27:422–431. 2006.
74.
DamascenoDC, VolpatoGT, de Mattos Paranhos CalderonI, Cunha RudgeMV. Oxidative stress and diabetes in pregnant rats. Anim Reprod Sci, 72:235–244. 2002.
75.
Davari-TanhaF, Khan-MohamadiF, KavehM, ShariatM. Homocysteine in gestational diabetes and normal pregnancy plus effects of folic acid. Iran J Public Health, 37:118–126. 2008.
76.
DehghanA, van HoekM, SijbrandsEJ, HofmanA, WittemanJC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care, 31:361–362. 2008.
77.
DenneryPA. Effects of oxidative stress on embryonic development. Birth Defects Res C Embryo Today, 81:155–162. 2007.
78.
DesoyeG, Hauguel-de MouzonS. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care, 30,Suppl 2:S120–S126. 2007.
79.
DesoyeG, HofmannHH, WeissPA. Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia, 35:45–55. 1992.
80.
DesoyeG, ShafrirE. Placental metabolism and its regulation in health and diabetes. Mol Aspects Med, 15:505–682. 1994.
81.
DesoyeG, ShafrirE. The human placenta in diabetic pregnancy. Diabetes Rev, 4:70–89. 1996.
82.
DeyP, GuptaP, AcharyaNK, RaoSN, RayS, ChakrabartyS, RamprasadS, KurianTA, MawrohA, KunduA, BhakthaG, JosephCP, KumarP, RaiL, RaoA. Antioxidants and lipid peroxidation in gestational diabetes—a preliminary study. Indian J Physiol Pharmacol, 52:149–156. 2008.
83.
Di IulioJL, GudeNM, KingRG, LiCG, RandMJ, BrenneckeSP. Human placental nitric oxide synthase activity is not altered in diabetes. Clin Sci (Lond), 97:123–128. 1999.
84.
DiderholmB, StridsbergM, EwaldU, Lindeberg-NordenS, GustafssonJ. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG, 112:713–718. 2005.
85.
EctorBJ, MageeJB, HegwoodCP, CoignMJ. Resveratrol concentration in muscadine berries, juice, pomace, purees, seeds, and wines. Am J Enol Vitic, 47:57–62. 1996.
86.
El-RemessyAB, Al-ShabraweyM, PlattDH, BartoliM, BehzadianMA, GhalyN, TsaiN, MotamedK, CaldwellRB. Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J, 21:2528–2539. 2007.
87.
EricssonA, HamarkB, PowellTL, JanssonT. Glucose transporter isoform 4 is expressed in the syncytiotrophoblast of first trimester human placenta. Hum Reprod, 20:521–530. 2005.
ErikssonUJ, CederbergJ, WentzelP. Congenital malformations in offspring of diabetic mothers—animal and human studies. Rev Endocr Metab Disord, 4:79–93. 2003.
90.
ErikssonUJ, SimanCM. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes, 45:1497–1502. 1996.
91.
EscuderoC, SobreviaL. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta, 29:469–483. 2008.
92.
Ethier-ChiassonM, ForestJC, GiguereY, MasseA, Marseille-TremblayC, LevyE, LafondJ. Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies. Reproduction, 136:491–502. 2008.
93.
EvansJL, GoldfineID, MadduxBA, GrodskyGM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev, 23:599–622. 2002.
94.
FanE, ZhangL, JiangS, BaiY. Beneficial effects of resveratrol on atherosclerosis. J Med Food, 11:610–614. 2008.
95.
FariasM, PueblaC, WestermeierF, JoMJ, Pastor-AngladaM, CasanelloP, SobreviaL. Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes. Cardiovasc Res, 86:45–54. 2010.
96.
FasshauerM, SeegerJ, WaldeyerT, SchreyS, EbertT, LossnerU, BluherM, StumvollM, FaberR, StepanH. Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens, 26:1824–1828. 2008.
97.
FengQ, SongW, LuX, HamiltonJA, LeiM, PengT, YeeSP. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation, 106:873–879. 2002.
98.
FetitaLS, SobngwiE, SerradasP, CalvoF, GautierJF. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab, 91:3718–3724. 2006.
99.
FigueroaR, MartinezE, FayngershRP, TejaniN, MohazzabHK, WolinMS. Alterations in relaxation to lactate and H(2)O(2) in human placental vessels from gestational diabetic pregnancies. Am J Physiol Heart Circ Physiol, 278:H706–H713. 2000.
100.
ForbesJM, CoughlanMT, CooperME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes, 57:1446–1454. 2008.
101.
FriedmanJE, IshizukaT, ShaoJ, HustonL, HighmanT, CatalanoP. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes, 48:1807–1814. 1999.
102.
FriedmanJE, KirwanJP, JingM, PresleyL, CatalanoPM. Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes, 57:606–613. 2008.
FurchgottRF, ZawadzkiJV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288:373–376. 1980.
105.
GaoL, LiuWH, LuanNN, FengC, ShangT. Correlation between the expression of high mobility group box 1 and receptor for advanced glycation end products and the onset of pre-eclampsia. Zhonghua Fu Chan Ke Za Zhi, 43:746–750. 2008.
106.
GaoL, MannGE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res, 82:9–20. 2009.
107.
GaoX, ZhangH, SchmidtAM, ZhangC. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol, 295:H491–H498. 2008.
108.
GaoZ, HwangD, BatailleF, LefevreM, YorkD, QuonMJ, YeJ. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem, 277:48115–48121. 2002.
109.
GareskogM, ErikssonUJ, WentzelP. Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Res A Clin Mol Teratol, 76:483–490. 2006.
110.
GarrisDR. Effects of diabetes on uterine condition, decidualization, vascularization, and corpus luteum function in the pseudopregnant rat. Endocrinology, 122:665–672. 1988.
111.
GarveyWT, MaianuL, HancockJA, GolichowskiAM, BaronA. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes, 41:465–475. 1992.
GerberRT, HolemansK, O'Brien-CokerI, MalletAI, van BreeR, Van AsscheFA, PostonL. Increase of the isoprostane 8-isoprostaglandin f2alpha in maternal and fetal blood of rats with streptozotocin-induced diabetes: evidence of lipid peroxidation. Am J Obstet Gynecol, 183:1035–1040. 2000.
115.
GetahunD, NathC, AnanthCV, ChavezMR, SmulianJC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol, 198:525.e1–5. 2008.
116.
GloireG, Legrand-PoelsS, PietteJ. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol, 72:1493–1505. 2006.
117.
GohSY, CooperME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab, 93:1143–1152. 2008.
118.
GonzalezE, JawerbaumA, NovaroV, SinnerD, GimenoM. Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat. Prostaglandins Leukot Essent Fatty Acids, 59:299–304. 1998.
119.
GonzalezM, GallardoV, RodriguezN, SalomonC, WestermeierF, Guzman-GutierrezE, AbarzuaF, LeivaA, CasanelloP, SobreviaL. Insulin-stimulated L-arginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. J Cell Physiol, 2011[Epub ahead of print];DOI:10.1002/jcp.22635.
120.
GorovitsN, CuiL, BusikJV, RanallettaM, Hauguel de-MouzonS, CharronMJ. Regulation of hepatic GLUT8 expression in normal and diabetic models. Endocrinology, 144:1703–1711. 2003.
121.
GrissaO, AtegboJM, YessoufouA, TabkaZ, MiledA, JerbiM, DramaneKL, MoutairouK, ProstJ, HichamiA, KhanNA. Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl Res, 150:164–171. 2007.
122.
GrossinN, WautierMP, WautierJL. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology, 46:63–72. 2009.
123.
GudeNM, StevensonJL, RogersS, BestJD, KalionisB, HuismanMA, ErwichJJ, TimmerA, KingRG. GLUT12 expression in human placenta in first trimester and term. Placenta, 24:566–570. 2003.
124.
GuilloteauP, ZabielskiR, HammonHM, MetgesCC. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol, 60,Suppl 3:17–35. 2009.
125.
GupteS, LabinskyyN, GupteR, CsiszarA, UngvariZ, EdwardsJG. Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM. PLoS One, 5:e11800. 2010.
126.
HagayZJ, WeissY, ZusmanI, Peled-KamarM, ReeceEA, ErikssonUJ, GronerY. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol, 173:1036–1041. 1995.
127.
HaggartyP. Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr, 58:1559–1570. 2004.
128.
HalliwellB, GutteridgeJMC. Free Radicals in Biology and Medicine, 4th. Oxford, NY: Oxford University Press, 2007.
129.
HannemannMM, LiddellWG, ShoreAC, ClarkPM, TookeJE. Vascular function in women with previous gestational diabetes mellitus. J Vasc Res, 39:311–319. 2002.
130.
HarrisLK, McCormickJ, CartwrightJE, WhitleyGS, DashPR. S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion. Exp Cell Res, 314:1765–1776. 2008.
131.
HarrisMI. Gestational diabetes may represent discovery of preexisting glucose intolerance. Diabetes Care, 11:402–411. 1988.
132.
Hauguel-de MouzonS, ChallierJC, KacemiA, CauzacM, MalekA, GirardJ. The GLUT3 glucose transporter isoform is differentially expressed within human placental cell types. J Clin Endocrinol Metab, 82:2689–2694. 1997.
133.
HayWWJr.Glucose metabolism in the fetal-placental unit. Principles of Perinatal-Neonatal Metabolism. CowettR.New York: Springer, 1998; 337–367.
134.
HermanJB, GoldbourtU. Uric acid and diabetes: observations in a population study. Lancet, 2:240–243. 1982.
135.
HerreraE. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development—a review. Placenta, 23,Suppl A:S9–S19. 2002.
136.
HerreraE. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine, 19:43–55. 2002.
137.
HerringSJ, OkenE. Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle?Curr Diab Rep, 11:20–27. 2011.
138.
HidenU, GlitznerE, IvanisevicM, DjelmisJ, WadsackC, LangU, DesoyeG. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-α levels. Diabetes, 57:150–157. 2008.
139.
HigaR, GonzalezE, PustovrhMC, WhiteV, CapobiancoE, MartinezN, JawerbaumA. PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis. Mol Hum Reprod, 13:103–110. 2007.
140.
HigaR, WhiteV, MartinezN, KurtzM, CapobiancoE, JawerbaumA. Safflower and olive oil dietary treatments rescue aberrant embryonic arachidonic acid and nitric oxide metabolism and prevent diabetic embryopathy in rats. Mol Hum Reprod, 16:286–295. 2010.
141.
HockettPK, EmerySC, HansenL, MasliahE. Evidence of oxidative stress in the brains of fetuses with CNS anomalies and islet cell hyperplasia. Pediatr Dev Pathol, 7:370–379. 2004.
142.
Holdsworth-CarsonSJ, LimR, MittonA, WhiteheadC, RiceGE, PermezelM, LappasM. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta, 31:222–229. 2010.
143.
HolemansK, GerberRT, MeurrensK, De ClerckF, PostonL, Van AsscheFA. Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia, 42:81–89. 1999.
144.
HorvathEM, MagenheimR, KuglerE, VaczG, SzigethyA, LevardiF, KollaiM, SzaboC, LaczaZ. Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia, 52:1935–1943. 2009.
145.
HotamisligilGS. Inflammation and metabolic disorders. Nature, 444:860–867. 2006.
146.
IgnarroLJ, BugaGM, WoodKS, ByrnsRE, ChaudhuriG. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA, 84:9265–9269. 1987.
147.
InnisSM. Essential fatty acid transfer and fetal development. Placenta, 26,Suppl A:S70–S75. 2005.
148.
JainM, BrennerDA, CuiL, LimCC, WangB, PimentelDR, KohS, SawyerDB, LeopoldJA, HandyDE, LoscalzoJ, ApsteinCS, LiaoR. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res, 93:e9–e16. 2003.
149.
JainSK, McVieR, SmithT. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care, 23:1389–1394. 2000.
150.
JaiswalM, LaRussoNF, GoresGJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol, 281:G626–G634. 2001.
151.
JanssonT, CetinI, PowellTL, DesoyeG, RadaelliT, EricssonA, SibleyCP. Placental transport and metabolism in fetal overgrowth—a workshop report. Placenta, 27,Suppl A:S109–S113. 2006.
152.
JanssonT, EkstrandY, BjornC, WennergrenM, PowellTL. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes, 51:2214–2219. 2002.
153.
This reference has been deleted.
154.
JanssonT, PowellTL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond), 113:1–13. 2007.
155.
JarvieE, Hauguel-de-MouzonS, NelsonSM, SattarN, CatalanoPM, FreemanDJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond), 119:123–129. 2010.
156.
JawerbaumA, CapobiancoE, PustovrhC, WhiteV, BaierM, SalzbergS, PesaresiM, GonzalezE. Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand 15-deoxy Δ12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod, 10:671–676. 2004.
157.
This reference has been deleted.
158.
JawerbaumA, GonzalezE. The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des, 11:1327–1342. 2005.
159.
JawerbaumA, GonzalezE. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem, 13:2127–2138. 2006.
160.
JawerbaumA, HigaR, WhiteV, CapobiancoE, PustovrhC, SinnerD, MartinezN, GonzalezE. Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis. Reproduction, 130:695–703. 2005.
161.
JawerbaumA, SinnerD, WhiteV, PustovrhC, CapobiancoE, GonzalezE. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. Reproduction, 124:625–631. 2002.
162.
JawerbaumA, WhiteV. Animal models in diabetes and pregnancy. Endocr Rev, 31:680–701. 2010.
163.
JirkovskaM, KubinovaL, JanacekJ, MoravcovaM, KrejciV, KarenP. Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res, 39:268–278. 2002.
164.
JonesCJ, DesoyeG. Glycogen distribution in the capillaries of the placental villus in normal, overt and gestational diabetic pregnancy. Placenta, 14:505–517. 1993.
165.
JonesKL, de KretserDM, PatellaS, PhillipsDJ. Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol, 225:119–125. 2004.
166.
JonesRH, OzanneSE. Intra-uterine origins of type 2 diabetes. Arch Physiol Biochem, 113:25–29. 2007.
167.
KamathU, RaoG, RaghothamaC, RaiL, RaoP. Erythrocyte indicators of oxidative stress in gestational diabetes. Acta Paediatr, 87:676–679. 1998.
168.
KasapinovicS, McCallumGP, WileyMJ, WellsPG. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice. Free Radic Biol Med, 37:1703–1711. 2004.
169.
KatsuyamaK, ShichiriM, MarumoF, HirataY. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Arterioscler Thromb Vasc Biol, 18:1796–1802. 1998.
170.
KaufmannP, BlackS, HuppertzB. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod, 69:1–7. 2003.
171.
Kautzky-WillerA, FaschingP, JilmaB, WaldhauslW, WagnerOF. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab, 82:4117–4121. 1997.
KharbS. Lipid peroxidation in pregnancy with preeclampsia and diabetes. Gynecol Obstet Invest, 50:113–116. 2000.
175.
KharbS. Ascorbic acid and uric acid levels in gestational diabetes mellitus. J Obstet Gynecol India, 27:401–402. 2007.
176.
KhullarS, GreenwoodSL, McCordN, GlazierJD, AyukPT. Nitric oxide and superoxide impair human placental amino acid uptake and increase Na+ permeability: implications for fetal growth. Free Radic Biol Med, 36:271–277. 2004.
177.
KilincM, GuvenM, EzerM, ErtasI, CoskunA. Evaluation of serum selenium levels in Turkish women with gestational diabetes mellitus, glucose intolerants, and normal controls. Biol Trace Elem Res, 123:35–40. 2008.
178.
This reference has been deleted.
179.
KimYM, BombeckCA, BilliarTR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res, 84:253–256. 1999.
180.
KinalskiM, SledziewskiA, TelejkoB, KowalskaI, KretowskiA, KinalskaI. Evaluation of lipid peroxidation and acid-base status in cord blood of newborns after diabetes in pregnancy. Przegl Lek, 58:120–123. 2001.
181.
KinalskiM, SledziewskiA, TelejkoB, KowalskaI, KretowskiA, ZarzyckiW, KinalskaI. Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res, 33:227–231. 2001.
182.
KinalskiM, SledziewskiA, TelejkoB, ZarzyckiW, KinalskaI. Lipid peroxidation and scavenging enzyme activity in streptozotocin-induced diabetes. Acta Diabetol, 37:179–183. 2000.
KirwanJP, Hauguel-De MouzonS, LepercqJ, ChallierJC, Huston-PresleyL, FriedmanJE, KalhanSC, CatalanoPM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes, 51:2207–2213. 2002.
185.
KleinK, SatlerM, ElhenickyM, BrixJ, KrzyzanowskaK, SchernthanerG, HussleinPW, SchernthanerG-H. Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat Diagn, 28:845–851. 2008.
186.
KnoppRH, MontesA, ChildsM, LiJR, MabuchiH. Metabolic adjustments in normal and diabetic pregnancy. Clin Obstet Gynecol, 24:21–49. 1981.
187.
KonishiH, NakatsukaM, ChekirC, NoguchiS, KamadaY, SasakiA, HiramatsuY. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod, 19:2156–2162. 2004.
188.
KossenjansW, EisA, SahayR, BrockmanD, MyattL. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol, 278:H1311–H1319. 2000.
189.
KourieJI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol, 275:C1–C24. 1998.
190.
KowluruRA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes, 52:818–823. 2003.
191.
KrishnaveniGV, HillJC, VeenaSR, BhatDS, WillsAK, KaratCL, YajnikCS, FallCH. Low plasma vitamin B12 in pregnancy is associated with gestational ‘diabesity’ and later diabetes. Diabetologia, 52:2350–2358. 2009.
192.
KronckeKD, FehselK, Kolb-BachofenV. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol, 113:147–156. 1998.
193.
KukorZ, ValentS, TothM. Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies. Placenta, 21:763–772. 2000.
194.
KumarSD, DheenST, TaySS. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol, 6:34. 2007.
195.
KurtzM, CapobiancoE, MartinezN, FernandezJ, HigaR, WhiteV, JawerbaumA. Carbaprostacyclin, a PPARdelta agonist, ameliorates excess lipid accumulation in diabetic rat placentas. Life Sci, 86:781–790. 2010.
196.
LachiliB, HiningerI, FaureH, ArnaudJ, RichardMJ, FavierA, RousselAM. Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation. Biol Trace Elem Res, 83:103–110. 2001.
197.
LagerS, JanssonN, OlssonAL, WennergrenM, JanssonT, PowellTL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta, 32:121–127. 2011.
198.
LangerO. Changing the diagnosis criteria of type 2 diabetes in pregnancy: do the ends justify the means?J Matern Fetal Neonatal Med, 23:234–238. 2010.
199.
LangerO, ConwayDL, BerkusMD, XenakisEM, GonzalesO. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med, 343:1134–1138. 2000.
200.
LaoTT, ChanLY, TamKF, HoLF. Maternal hemoglobin and risk of gestational diabetes mellitus in Chinese women. Obstet Gynecol, 99:807–812. 2002.
201.
LaoTT, ChanPL, TamKF. Gestational diabetes mellitus in the last trimester—a feature of maternal iron excess?Diabet Med, 18:218–223. 2001.
202.
LaoTT, TamKF. Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care, 20:1368–1369. 1997.
203.
LappasM, MittonA, LimR, BarkerG, RileyC, PermezelM. SIRT1 is a novel regulator of key pathways of human labor. Biol Reprod, 84:167–178. 2011.
204.
LappasM, MittonA, PermezelM. In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J Endocrinol, 204:75–84. 2010.
205.
LappasM, PermezelM, GeorgiouHM, RiceGE. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab, 87:4667–4672. 2002.
206.
LappasM, PermezelM, HoPW, MoseleyJM, WlodekME, RiceGE. Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. Placenta, 25:699–704. 2004.
207.
LappasM, PermezelM, RiceGE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab, 88:1723–1729. 2003.
208.
LappasM, PermezelM, RiceGE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab, 89:5627–5633. 2004.
209.
LappasM, PermezelM, RiceGE. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta, 27:1060–1072. 2006.
210.
LappasM, PermezelM, RiceGE. Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Endocrinol, 193:269–277. 2007.
211.
This reference has been deleted.
212.
LappasM, RileyC, RiceGE, PermezelM. Increased expression of ac-FoxO1 protein in prelabor fetal membranes overlying the cervix: possible role in human fetal membrane rupture. Reprod Sci, 16:635–641. 2009.
213.
LappasM, YeeK, PermezelM, RiceGE. Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta, 27:568–575. 2006.
214.
LarsenN, VogensenFK, van den BergFW, NielsenDS, AndreasenAS, PedersenBK, Al-SoudWA, SorensenSJ, HansenLH, JakobsenM. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5:e9085. 2010.
215.
LauenborgJ, GrarupN, DammP, Borch-JohnsenK, JorgensenT, PedersenO, HansenT. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab, 94:145–150. 2009.
216.
LeeQP, JuchauMR. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine. Teratology, 49:452–464. 1994.
217.
LeitchI, OsmondD, FalconerJ, CliftonV, WaltersW, ReadM. Vasoactive effects of 8-epi-prostaglandin-F2alpha in the human placenta in vitro. J Soc Gynecol Invest, 6:195A. 1999.
218.
LesserKB, CarpenterMW. Metabolic changes associated with normal pregnancy and pregnancy complicated by diabetes mellitus. Semin Perinatol, 18:399–406. 1994.
219.
LiH, GuB, ZhangY, LewisDF, WangY. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta, 26:210–217. 2005.
220.
LoekenMR. Advances in understanding the molecular causes of diabetes-induced birth defects. J Soc Gynecol Investig, 13:2–10. 2006.
221.
LohTT, HiguchiDA, van BockxmeerFM, SmithCH, BrownEB. Transferrin receptors on the human placental microvillous membrane. J Clin Invest, 65:1182–1191. 1980.
222.
LoukovaaraMJ, LoukovaaraS, LeinonenPJ, TeramoKA, AnderssonSH. Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies. Eur J Obstet Gynecol Reprod Biol, 118:160–165. 2005.
LunghiL, FerrettiME, MediciS, BiondiC, VesceF. Control of human trophoblast function. Reprod Biol Endocrinol, 5:6. 2007.
225.
LuoZC, FraserWD, JulienP, DealCL, AudibertF, SmithGN, XiongX, WalkerM. Tracing the origins of “fetal origins” of adult diseases: programming by oxidative stress?Med Hypotheses, 66:38–44. 2006.
226.
LuotoR, LaitinenK, NermesM, IsolauriE. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr, 103:1792–1799. 2010.
227.
LurieS, MatasZ, BoazM, FuxA, GolanA, SadanO. Different degrees of fetal oxidative stress in elective and emergent cesarean section. Neonatology, 92:111–115. 2007.
228.
LyallF, GibsonJL, GreerIA, BrockmanDE, EisAL, MyattL. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care, 21:1753–1758. 1998.
229.
MacMickingJ, XieQW, NathanC. Nitric oxide and macrophage function. Annu Rev Immunol, 15:323–350. 1997.
230.
MadazliR, TutenA, CalayZ, UzunH, UludagS, OcakV. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest, 65:227–232. 2008.
231.
MaedaH, OkamotoT, AkaikeT. Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem, 379:193–200. 1998.
232.
MaggirwarSB, DhanrajDN, SomaniSM, RamkumarV. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun, 201:508–515. 1994.
233.
MahadevK, MotoshimaH, WuX, RuddyJM, ArnoldRS, ChengG, LambethJD, GoldsteinBJ. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol, 24:1844–1854. 2004.
234.
MandangS, ManuelpillaiU, WallaceEM. Oxidative stress increases placental and endothelial cell activin A secretion. J Endocrinol, 192:485–493. 2007.
235.
ManeaA, TanaseLI, RaicuM, SimionescuM. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophys Res Commun, 396:901–907. 2010.
236.
MannGE, RowlandsDJ, LiFY, de WinterP, SiowRC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res, 75:261–274. 2007.
237.
MaritimAC, SandersRA, WatkinsJB. 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol, 17:24–38. 2003.
238.
MatsubaraS, TakizawaT, SuzukiT, MinakamiH, SatoI. Glucose-6-phosphate dehydrogenase is present in normal and pre-eclamptic placental trophoblasts: ultrastructural enzyme-histochemical evidence. Placenta, 22:90–95. 2001.
McCanceDR, HolmesVA, MareshMJ, PattersonCC, WalkerJD, PearsonDW, YoungIS. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet, 376:259–266. 2010.
241.
MedalieJH, PapierCM, GoldbourtU, HermanJB. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med, 135:811–817. 1975.
242.
MelamedN, ChenR, SoibermanU, Ben-HaroushA, HodM, YogevY. Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors. Arch Gynecol Obstet, 278:129–134. 2008.
243.
MetzgerBE, PhelpsRL, FreinkelN, NavickasIA. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care, 3:402–409. 1980.
244.
MichalikL, AuwerxJ, BergerJP, ChatterjeeVK, GlassCK, GonzalezFJ, GrimaldiPA, KadowakiT, LazarMA, O'RahillyS, PalmerCNA, PlutzkyJ, ReddyJK, SpiegelmanBM, StaelsB, WahliW. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev, 58:726–741. 2006.
245.
MilczarekR, KlimekJ, ZelewskiL. The effects of ascorbate and alpha-tocopherol on the NADPH-dependent lipid peroxidation in human placental mitochondria. Mol Cell Biochem, 210:65–73. 2000.
246.
MilnerRD, HillDJ. Fetal growth control: the role of insulin and related peptides. Clin Endocrinol (Oxf), 21:415–433. 1984.
247.
MinkPJ, ScraffordCG, BarrajLM, HarnackL, HongCP, NettletonJA, JacobsDRJr.Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr, 85:895–909. 2007.
MittermayerF, MayerBX, MeyerA, WinzerC, PaciniG, WagnerOF, WolztM, Kautzky-WillerA. Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes. Diabetologia, 45:1372–1378. 2002.
250.
MoelleringD, Mc AndrewJ, PatelRP, FormanHJ, MulcahyRT, JoH, Darley-UsmarVM. The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase. FEBS Lett, 448:292–296. 1999.
251.
MoleyKH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab, 12:78–82. 2001.
MontalbettiN, CanteroMR, DalghiMG, CantielloHF. Reactive oxygen species inhibit polycystin-2 (TRPP2) cation channel activity in term human syncytiotrophoblast. Placenta, 29:510–518. 2008.
254.
MorganSC, RelaixF, SandellLL, LoekenMR. Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects. Birth Defects Res A Clin Mol Teratol, 82:453–463. 2008.
255.
MuradF, MittalCK, ArnoldWP, KatsukiS, KimuraH. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res, 9:145–158. 1978.
256.
MustafaS, VukovichT, PrikoszovichT, WinzerC, SchneiderB, EsterbauerH, WagnerO, Kautzky-WillerA. Haptoglobin phenotype and gestational diabetes. Diabetes Care, 27:2103–2107. 2004.
MyattL. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta, 31,Suppl:S66–S69. 2010.
259.
MyattL, CuiX. Oxidative stress in the placenta. Histochem Cell Biol, 122:369–382. 2004.
260.
NagareddyPR, SolimanH, LinG, RajputPS, KumarU, McNeillJH, MacLeodKM. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes, 58:2355–2364. 2009.
261.
NavarroA, AlonsoA, GarridoP, GonzalezC, del ReyCG, OrdonezC, ToliviaJ. Increase in placental apolipoprotein D as an adaptation to human gestational diabetes. Placenta, 31:25–31. 2010.
262.
NeerhofMG, SynowiecS, KhanS, ThaeteLG. Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat. Hypertens Pregnancy, 30:28–36. 2011.
263.
NishikawaT, EdelsteinD, DuXL, YamagishiS, MatsumuraT, KanedaY, YorekMA, BeebeD, OatesPJ, HammesHP, GiardinoI, BrownleeM. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404:787–790. 2000.
264.
NolanCJ, ProiettoJ. The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia, 37:976–984. 1994.
265.
NorwitzER, SchustDJ, FisherSJ. Implantation and the survival of early pregnancy. N Engl J Med, 345:1400–1408. 2001.
NovaroV, JawerbaumA, FalettiA, GimenoMA, GonzalezET. Uterine nitric oxide and prostaglandin E during embryonic implantation in non-insulin-dependent diabetic rats. Reprod Fertil Dev, 10:217–223. 1998.
268.
NovaroV, PustovrhC, Colman-LernerA, RadiskyD, Lo NostroF, PazD, JawerbaumA, GonzalezE. Nitric oxide induces gelatinase A (matrix metalloproteinase 2) during rat embryo implantation. Fertil Steril, 78:1278–1287. 2002.
269.
OettlK, StauberRE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol, 151:580–590. 2007.
270.
OkazakiT, OtaniH, ShimazuT, YoshiokaK, FujitaM, KatanoT, ItoS, IwasakaT. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J Mol Cell Cardiol, 50:534–544. 2011.
271.
OkunoS, AkazawaS, YasuhiI, KawasakiE, MatsumotoK, YamasakiH, MatsuoH, YamaguchiY, NagatakiS. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm Metab Res, 27:231–234. 1995.
272.
OnozatoML, TojoA, GotoA, FujitaT. Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. Kidney Int, 65:951–960. 2004.
273.
OrhanH, OnderogluL, YucelA, SahinG. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet, 267:189–195. 2003.
274.
OrnoyA. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol, 24:31–41. 2007.
275.
OrnoyA, TsadokMA, YaffeP, ZangenSW. The Cohen diabetic rat as a model for fetal growth restriction: vitamins C and E reduce fetal oxidative stress but do not restore normal growth. Reprod Toxicol, 28:521–529. 2009.
276.
PacherP, BeckmanJS, LiaudetL. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 87:315–424. 2007.
277.
PacherP, ObrosovaIG, MableyJG, SzaboC. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem, 12:267–275. 2005.
278.
PavanL, HermouetA, TsatsarisV, TherondP, SawamuraT, Evain-BrionD, FournierT. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology, 145:4583–4591. 2004.
279.
Pertynska-MarczewskaM, GlowackaE, SobczakM, CyprykK, WilczynskiJ. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am J Reprod Immunol, 61:175–182. 2009.
280.
PesslerD, RudichA, BashanN. Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter. Diabetologia, 44:2156–2164. 2001.
PeuchantE, BrunJL, RigalleauV, DubourgL, ThomasMJ, DanielJY, LengJJ, GinH. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem, 37:293–298. 2004.
283.
PeunovaN, EnikolopovG. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature, 375:68–73. 1995.
284.
PinkneyJH, StehouwerCD, CoppackSW, YudkinJS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes, 46,Suppl 2:S9–S13. 1997.
285.
PlachtaN, TraisterA, WeilM. Nitric oxide is involved in establishing the balance between cell cycle progression and cell death in the developing neural tube. Exp Cell Res, 288:354–362. 2003.
PuntaruloS. Iron, oxidative stress and human health. Mol Aspects Med, 26:299–312. 2005.
288.
PustovrhC, JawerbaumA, SinnerD, PesaresiM, BaierM, MiconeP, GimenoM, GonzalezET. Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev, 12:269–275. 2000.
289.
PustovrhMC, CapobiancoE, MartinezN, HigaR, WhiteV, JawerbaumA. MMP/TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. Eur J Clin Invest, 39:1082–1090. 2009.
290.
PustovrhMC, JawerbaumA, CapobiancoE, WhiteV, Lopez-CostaJJ, GonzalezE. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta, 26:339–348. 2005.
291.
PustovrhMC, JawerbaumA, CapobiancoE, WhiteV, MartinezN, Lopez-CostaJJ, GonzalezE. Oxidative stress promotes the increase of matrix metalloproteinases-2 and −9 activities in the feto-placental unit of diabetic rats. Free Radic Res, 39:1285–1293. 2005.
292.
PustovrhMC, JawerbaumA, WhiteV, CapobiancoE, HigaR, MartinezN, Lopez-CostaJJ, GonzalezE. The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats. Reproduction, 134:605–613. 2007.
293.
RadaelliT, VarastehpourA, CatalanoP, Hauguel-de MouzonS. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes, 52:2951–3958. 2003.
294.
RahmanA, KeferJ, BandoM, NilesWD, MalikAB. E-selectin expression in human endothelial cells by TNF-alpha -induced oxidant generation and NF-kappa B activation. Am J Physiol Lung Cell Mol Physiol, 275:L533–L544. 1998.
295.
RajapakseAG, MingXF, CarvasJM, YangZ. The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects. Am J Physiol Heart Circ Physiol, 296:H815–H822. 2009.
296.
RajdlD, RacekJ, SteinerovaA, NovotnyZ, StozickyF, TrefilL, SialaK. Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol Res, 54:429–436. 2005.
297.
RajeshM, MukhopadhyayP, BatkaiS, MukhopadhyayB, PatelV, HaskoG, SzaboC, MableyJG, LiaudetL, PacherP. Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med, 13:2330–2341. 2009.
298.
RazaH, JohnA. Glutathione metabolism and oxidative stress in neonatal rat tissues from streptozotocin-induced diabetic mothers. Diabetes Metab Res Rev, 20:72–78. 2004.
299.
ReadMA, BouraAL, WaltersWA. Vascular actions of purines in the foetal circulation of the human placenta. Br J Pharmacol, 110:454–460. 1993.
300.
RetiNG, LappasM, RileyC, WlodekME, PermezelM, WalkerS, RiceGE. Why do membranes rupture at term? Evidence of increased cellular apoptosis in the supracervical fetal membranes. Am J Obstet Gynecol, 196:484.e1–10. 2007.
301.
RobertsVHJ, SmithJ, McleaSA, HeizerAB, RichardsonJL, MyattL. Effect of Increasing Maternal Body Mass Index on Oxidative and Nitrative Stress in the Human Placenta. Oxford, ROYAUME-UNI: Elsevier, 2009; 7.
302.
RochaSO, GomesGN, FortiAL, do Carmo Pinho FrancoM, FortesZB, de Fatima CavanalM, GilFZ. Long-term effects of maternal diabetes on vascular reactivity and renal function in rat male offspring. Pediatr Res, 58:1274–1279. 2005.
303.
RoloAP, PalmeiraCM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol, 212:167–178. 2006.
304.
RosenfeldCR, CoxBE, RoyT, MagnessRR. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest, 98:2158–2166. 1996.
305.
RubboH, RadiR, TrujilloM, TelleriR, KalyanaramanB, BarnesS, KirkM, FreemanBA. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem, 269:26066–26075. 1994.
306.
RyanEA, ImesS, LiuD, McManusR, FinegoodDT, PolonskyKS, SturisJ. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes, 44:506–512. 1995.
307.
RyuS, KohenR, SamuniA, OrnoyA. Nitroxide radicals protect cultured rat embryos and yolk sacs from diabetic-induced damage. Birth Defects Res A Clin Mol Teratol, 79:604–611. 2007.
308.
San MartinR, SobreviaL. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta, 27:1–10. 2006.
309.
SandersTH, McMichaelRWJr., HendrixKW. Occurrence of resveratrol in edible peanuts. J Agric Food Chem, 48:1243–1246. 2000.
310.
SankaralingamS, XuY, SawamuraT, DavidgeST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension, 53:270–277. 2009.
311.
SantraD, SawhneyH, AggarwalN, MajumdarS, VasishtaK. Lipid peroxidation and vitamin E status in gestational diabetes mellitus. J Obstet Gynaecol Res, 29:300–304. 2003.
312.
Schaefer-GrafUM, GrafK, KulbackaI, KjosSL, DudenhausenJ, VetterK, HerreraE. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care, 31:1858–1863. 2008.
313.
SchmidE, Hotz-WagenblattA, HacjV, DrogeW. Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide: the structural basis of redox priming. FASEB J, 13:1491–1500. 1999.
314.
SchonfelderG, JohnM, HoppH, FuhrN, van Der GietM, PaulM. Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J, 10:777–784. 1996.
315.
SenguptaJ, DhawanL, LalitkumarPG, GhoshD. Nitric oxide in blastocyst implantation in the rhesus monkey. Reproduction, 130:321–332. 2005.
316.
SgarbosaF, BarbisanLF, BrasilMA, CostaE, CalderonIM, GoncalvesCR, BevilacquaE, RudgeMV. Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract, 73:143–149. 2006.
317.
ShaatN, KarlssonE, LernmarkA, IvarssonS, LynchK, ParikhH, AlmgrenP, BerntorpK, GroopL. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia, 49:1545–1551. 2006.
318.
ShakibaeiM, HarikumarKB, AggarwalBB. Resveratrol addiction: to die or not to die. Mol Nutr Food Res, 53:115–128. 2009.
319.
ShaoJ, CatalanoPM, YamashitaH, RuyterI, SmithS, YoungrenJ, FriedmanJE. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes, 49:603–610. 2000.
320.
SidorkinaO, EspeyMG, MirandaKM, WinkDA, LavalJ. Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic Biol Med, 35:1431–1438. 2003.
321.
SimanCM, ErikssonUJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes, 46:1054–1061. 1997.
322.
SimpsonJL, EliasS, MartinAO, PalmerMS, OgataES, RadvanyRA. Diabetes in pregnancy, Northwestern University series (1977–1981). I. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol, 146:263–270. 1983.
323.
SivanE, HomkoCJ, WhittakerPG, ReeceEA, ChenX, BodenG. Free fatty acids and insulin resistance during pregnancy. J Clin Endocrinol Metab, 83:2338–2342. 1998.
324.
SivanE, LeeYC, WuYK, ReeceEA. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology, 56:343–349. 1997.
325.
SivanE, ReeceEA, WuYK, HomkoCJ, PolanskyM, BorensteinM. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol, 175:793–799. 1996.
326.
SoaresDG, AndreazzaAC, SalvadorM. Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J Agric Food Chem, 51:1077–1080. 2003.
327.
SobkiSH, Al-SenaidyAM, Al-ShammariTA, InamSS, Al-GwiserAA, BukhariSA. Impact of gestational diabetes on lipid profiling and indices of oxidative stress in maternal and cord plasma. Saudi Med J, 25:876–880. 2004.
SobreviaL, CesareP, YudilevichDL, MannGE. Diabetes-induced activation of system y+ and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol, 489,Pt 1:183–192. 1995.
330.
SobreviaL, YudilevichDL, MannGE. Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies. J Physiol, 506,Pt 1:219–230. 1998.
331.
SoubasiV, PetridouS, SarafidisK, TsantaliC, DiamantiE, BuonocoreG, Drossou-AgakidouV. Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation. Diabetes Metab, 36:58–63. 2010.
332.
SparksSP, Jovanovic-PetersonL, PetersonCM. Blood glucose rise following prenatal vitamins in gestational diabetes. J Am Coll Nutr, 12:543–546. 1993.
333.
StanleyJL, SankaralingamS, BakerPN, DavidgeST. Previous gestational diabetes impairs long-term endothelial function in a mouse model of complicated pregnancy. Am J Physiol Regul Integr Comp Physiol, 299:R862–R870. 2010.
334.
SteinhublSR. Why have antioxidants failed in clinical trials?Am J Cardiol, 101:14D–19D. 2008.
335.
SugimuraY, MuraseT, OyamaK, UchidaA, SatoN, HayasakaS, KanoY, TakagishiY, HayashiY, OisoY, MurataY. Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes. Diabetologia, 52:962–971. 2009.
336.
SurapaneniKM, Vishnu PriyaV. Antioxidant enzymes and vitamins in gestational diabetes. J Clin Diagn Res, 2:1081–1085. 2008.
337.
This reference has been deleted.
338.
SuzukiT, NagamatsuC, KushimaT, MiyakoshiR, TanakaK, MoritaH, SakaueM, TakizawaT. Apoptosis caused by an inhibitor of NO production in the decidua of rat from mid-gestation. Exp Biol Med (Maywood), 235:455–462. 2010.
339.
SzetoIMY, AzizA, DasPJ, TahaAY, OkuboN, Reza-LopezS, GiaccaA, AndersonGH. High multivitamin intake by Wistar rats during pregnancy results in increased food intake and components of the metabolic syndrome in male offspring. Am J Physiol Regul Integr Comp Physiol, 295:R575–R582. 2008.
340.
TainYL, HsiehCS, LinIC, ChenCC, SheenJM, HuangLT. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide, 23:34–41. 2010.
341.
TanM, ShengL, QianY, GeY, WangY, ZhangH, JiangM, ZhangG. Changes of serum selenium in pregnant women with gestational diabetes mellitus. Biol Trace Elem Res, 83:231–237. 2001.
342.
TarimE, YigitF, KilicdagE, BagisT, DemircanS, SimsekE, HaydardedeogluB, YanikF. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol, 27:177–182. 2006.
343.
TeraoJ. Dietary flavonoids as antioxidants. Forum Nutr, 61:87–94. 2009.
344.
ThadhaniR, PoweCE, TjoaML, KhankinE, YeJ, EckerJ, SchneyerA, KarumanchiSA. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care, 33:664–669. 2010.
345.
ThalerCD, EpelD. Nitric oxide in oocyte maturation, ovulation, fertilization, cleavage and implantation: a little dab'll do ya. Curr Pharm Des, 9:399–409. 2003.
ThumT, FraccarolloD, SchultheissM, FroeseS, GaluppoP, WidderJD, TsikasD, ErtlG, BauersachsJ. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes, 56:666–674. 2007.
348.
ToescuV, NuttallSL, MartinU, NightingaleP, KendallMJ, BrydonP, DunneF. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci (Lond), 106:93–98. 2004.
349.
TopelI, StanariusA, WolfG. Distribution of the endothelial constitutive nitric oxide synthase in the developing rat brain: an immunohistochemical study. Brain Res, 788:43–48. 1998.
350.
TorloniMR, BetranAP, HortaBL, NakamuraMU, AtallahAN, MoronAF, ValenteO. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev, 10:194–203. 2009.
351.
UmekawaT, SugiyamaT, KihiraT, MurabayashiN, ZhangL, NagaoK, KamimotoY, MaN, YodoiJ, SagawaN. Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism. Endocrinology, 149:3980–3988. 2008.
352.
Vaisanen-TommiskaMR. Nitric oxide in the human uterine cervix: endogenous ripening factor. Ann Med, 40:45–55. 2008.
353.
ValdesG, KaufmannP, CorthornJ, EricesR, BrosnihanKB, Joyner-GranthamJ. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol, 7:79. 2009.
354.
ValkoM, LeibfritzD, MoncolJ, CroninMTD, MazurM, TelserJ. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39:44–84. 2007.
355.
Van AsscheFA, De PrinsF, AertsL, VerjansM. The endocrine pancreas in small-for-dates infants. Br J Obstet Gynaecol, 84:751–753. 1977.
356.
VasquezG, SanhuezaF, VasquezR, GonzalezM, San MartinR, CasanelloP, SobreviaL. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol, 560:111–122. 2004.
357.
VianaM, AruomaOI, HerreraE, BonetB. Oxidative damage in pregnant diabetic rats and their embryos. Free Radic Biol Med, 29:1115–1121. 2000.
358.
VianaM, CastroM, BarbasC, HerreraE, BonetB. Effect of different doses of vitamin E on the incidence of malformations in pregnant diabetic rats. Ann Nutr Metab, 47:6–10. 2003.
359.
von MandachU, LauthD, HuchR. Maternal and fetal nitric oxide production in normal and abnormal pregnancy. J Matern Fetal Neonatal Med, 13:22–27. 2003.
360.
VonnahmeKA, WilsonME, LiY, RupnowHL, PhernettonTM, FordSP, MagnessRR. Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. J Physiol, 565:101–109. 2005.
361.
WangY, TanM, HuangZ, ShengL, GeY, ZhangH, JiangM, ZhangG. Elemental contents in serum of pregnant women with gestational diabetes mellitus. Biol Trace Elem Res, 88:113–118. 2002.
362.
WangY, WalshSW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta, 22:206–212. 2001.
363.
WeissU, CervarM, PuerstnerP, SchmutO, HaasJ, MauschitzR, ArikanG, DesoyeG. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia, 44:209–219. 2001.
364.
Weksler-ZangenS, YaffeP, OrnoyA. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions. Birth Defects Res A Clin Mol Teratol, 67:429–437. 2003.
365.
WentzelP, EjdesjöA, ErikssonUJ. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes, 52:1222–1228. 2003.
366.
WentzelP, ErikssonUJ. 8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro. Teratology, 66:164–168. 2002.
367.
WentzelP, GareskogM, ErikssonUJ. Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats. Diabetes, 57:3344–3352. 2008.
368.
WentzelP, WelshN, ErikssonUJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes, 48:813–820. 1999.
369.
WestermeierF, PueblaC, VegaJL, FariasM, EscuderoC, CasanelloP, SobreviaL. Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol, 7:435–449. 2009.
370.
WestermeierF, SalomonC, GonzalezM, PueblaC, Guzman-GutierrezE, CifuentesF, LeivaA, CasanelloP, SobreviaL. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes, 60:1677–1687. 2011.
371.
WhiteV, CapobiancoE, HigaR, MartinezN, SosaM, PustovrhMC, JawerbaumA. Increased nitration and diminished activity of copper/zinc superoxide dismutase in placentas from diabetic rats. Free Radic Res, 44:1407–1415. 2010.
372.
WhiteV, GonzalezE, CapobiancoE, PustovrhC, MartinezN, HigaR, BaierM, JawerbaumA. Leptin modulates nitric oxide production and lipid metabolism in human placenta. Reprod Fertil Dev, 18:425–432. 2006.
373.
WhiteV, GonzalezE, PustovrhC, CapobiancoE, MartinezN, Do PortoDF, HigaR, JawerbaumA. Leptin in embryos from control and diabetic rats during organogenesis: a modulator of nitric oxide production and lipid homeostasis. Diabetes Metab Res Rev, 23:580–588. 2007.
374.
WhiteV, JawerbaumA, SinnerD, PustovrhC, CapobiancoE, GonzalezE. Oxidative stress and altered prostanoid production in the placenta of streptozotocin-induced diabetic rats. Reprod Fertil Dev, 14:117–123. 2002.
375.
WhitleyGS, CartwrightJE. Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta, 31:465–474. 2010.
376.
WieserF, WaiteL, DepoixC, TaylorRN. PPAR action in human placental development and pregnancy and its complications. PPAR Res, 2008:527048. 2008.
377.
WinkDA, MirandaKM, EspeyMG, PlutaRM, HewettSJ, ColtonC, VitekM, FeelischM, GrishamMB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal, 3:203–213. 2001.
378.
WiznitzerA, AyalonN, HershkovitzR, KhamaisiM, ReeceEA, TrischlerH, BashanN. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol, 180:188–193. 1999.
379.
XiaL, WangH, MunkS, KwanJ, GoldbergHJ, FantusIG, WhitesideCI. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am J Physiol Renal Physiol, 295:F1705–F1714. 2008.
XingAY, ChallierJC, LepercqJ, CauzacM, CharronMJ, GirardJ, Hauguel-de MouzonS. Unexpected expression of glucose transporter 4 in villous stromal cells of human placenta. J Clin Endocrinol Metab, 83:4097–4101. 1998.
382.
XueM, QianQ, AdaikalakoteswariA, RabbaniN, Babaei-JadidiR, ThornalleyPJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes, 57:2809–2817. 2008.
383.
YallampalliC, GarfieldRE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol, 169:1316–1320. 1993.
384.
YangP, CaoY, LiH. Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation. Am J Obstet Gynecol, 203:185.e5–11. 2010.
385.
YessoufouA, SoulaimannN, MerzoukSA, MoutairouK, AhissouH, ProstJ, SimoninAM, MerzoukH, HichamiA, KhanNA. N-3 Fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes (Lond), 30:739–750. 2006.
386.
This reference has been deleted.
387.
YoungSL, EvansK, EuJP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol, 282:L379–L385. 2002.
388.
YuT, RobothamJL, YoonY. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA, 103:2653–2658. 2006.
389.
YuY, SinghU, ShiW, KonnoT, SoaresMJ, GeyerR, FundeleR. Influence of murine maternal diabetes on placental morphology, gene expression, and function. Arch Physiol Biochem, 114:99–110. 2008.
390.
YuanB, OhyamaK, TakeichiM, ToyodaH. Direct contribution of inducible nitric oxide synthase expression to apoptosis induction in primary smooth chorion trophoblast cells of human fetal membrane tissues. Int J Biochem Cell Biol, 41:1062–1069. 2009.
391.
ZabihiS, ErikssonUJ, WentzelP. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod Toxicol, 23:486–498. 2007.
392.
ZabihiS, WentzelP, ErikssonUJ. Altered uterine perfusion is involved in fetal outcome of diabetic rats. Placenta, 29:413–421. 2008.
393.
ZangenSW, YaffeP, ShechtmanS, ZangenDH, OrnoyA. The role of reactive oxygen species in diabetes-induced anomalies in embryos of Cohen diabetic rats. Int J Exp Diabetes Res, 3:247–255. 2002.
